By Oscar Pascual |
As if cannabis didn’t already have a huge amount of health benefits, New York based AXIM Biotechnologies has found another.
Dentistry.
The company recently introduced Oraximax, a line of cannabis-infused toothpaste, toothpaste and mouthwash. Even more impressive, the line is the first of its kind to be concentrated with the compound cannabigerol (CBG), reports main Street.
While not nearly as popular as THC or CBD, CBG is another cannabinoid known to possess anti-inflammatory and antibacterial properties.
AXIM Biotech says that CBG can help with certain conditions such as gingivitis or bleeding gums.
“There are 320 toothpastes on the market, all of which are very similar,” said dentist and AXIM Biotech CEO Dr. George Anastassov in an interview with main Street. “They prevent cavities and promote fresh breath, but AXIM’s CBG-derived oral care products eliminate the bacteria that build up in the mouth from the repeated trauma of eating, talking and brushing your teeth.”
CBGs are one of 85 cannabinoid compounds found in marijuana plants. The company is growing its own high CBG business called Asso to research and create new products.
“We work with a type of industrial hemp with a high content of CBGs and no THC, which we buy from a producer in Italy,” says Dr. Philip Van Damme, a physician and chief medical officer at AXIM Biotech, in MainStreet’s interview. “The compound also kills tumors and reduces eye pressure in glaucoma patients.”
The company is also developing a line of CBG-concentrated skin care products called Renecann, as well as a pain-relieving rub for relieving muscle pain. Van Damme believes his company is filling a void that the market hadn’t even imagined.
“The world’s population is aging with active lifestyles, which can cause pain, so there is a need for new pain treatments without side effects,” said Van Damme. main Street. “There are no new classes of pain relievers on the market, just NSAIDs and opioids and their combinations.”
Photo credit: GlobeNewswire
